Photo of Varsha V Gandhi

View Scopus Profile

Varsha V Gandhi

Professor

  • 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 11498 Citations
  • 59 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Varsha V Gandhi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
Arabinofuranosylcytosine Triphosphate Medicine & Life Sciences
Leukemia Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Nucleosides Medicine & Life Sciences
Apoptosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia

Buettner, R., Nguyen, L. X. T., Kumar, B., Morales, C., Liu, C., Chen, L. S., Pemovska, T., Synold, T. W., Palmer, J., Thompson, R., Li, L., Hoang, D. H., Zhang, B., Ghoda, L., Kowolik, C., Kontro, M., Leitch, C., Wennerberg, K., Yu, X., Chen, C. C. & 5 others, Horne, D., Gandhi, V. V., Pullarkat, V., Marcucci, G. & Rosen, S. T., Sep 1 2019, In : Journal of Cellular Physiology. 234, 9, p. 16295-16303 9 p.

Research output: Contribution to journal › Article

Acute Myeloid Leukemia
Adenosine
Stem cells
Stem Cells
Myeloid Cells

Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells

Vangapandu, H. V. & Gandhi, V. V., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 121-128 8 p. (Methods in Molecular Biology; vol. 1881).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Oxidative Phosphorylation
Glycolysis
B-Cell Chronic Lymphocytic Leukemia
Suspensions
Smegmamorpha

Ex Vivo Pharmacological Profiling in Chronic Lymphocytic Leukemia Cells

Aslan, B., Ayres, M. L. & Gandhi, V. V., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 19-25 7 p. (Methods in Molecular Biology; vol. 1881).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

B-Cell Chronic Lymphocytic Leukemia
Pharmacology
Pharmaceutical Preparations
Drug Combinations
Lymphocytes
4 Citations (Scopus)

Ibrutinib and venetoclax for first-line treatment of CLL

Jain, N., Keating, M., Thompson, P. A., Ferrajoli, A., Burger, J. A., Borthakur, G., Takahashi, K., Estrov, Z., Fowler, N., Kadia, T. M., Konopleva, M., Alvarado, Y., Yilmaz, M., DiNardo, C., Bose, P., Ohanian, M., Pemmaraju, N., Jabbour, E. J., Sasaki, K., Kanagal Shamanna, R. & 12 others, Patel, K. P., Jorgensen, J. L., Garg, N., Wang, X., Sondermann, K., Cruz, N., Wei, C., Ayala, A., Plunkett, W., Kantarjian, H. M., Gandhi, V. V. & Wierda, W. G., May 30 2019, In : New England Journal of Medicine. 380, 22, p. 2095-2103 9 p.

Research output: Contribution to journal › Article

B-Cell Chronic Lymphocytic Leukemia
Chromosome Deletion
Residual Neoplasm
Therapeutics
PCI 32765

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’

Bose, P., Chen, L. S. & Gandhi, V. V., Jun 7 2019, In : Leukemia and Lymphoma. 60, 7, p. 1603-1605 3 p.

Research output: Contribution to journal › Comment/debate

B-Cell Chronic Lymphocytic Leukemia
Learning
PCI 32765